Transvaginal Mesh Liability
Millions of women, especially post-menopausal mothers, suffer from pelvic organ prolapse (POP) or stress urinary incontinence (SUI). These common conditions may affect, to one degree or another, more than half of all women who have delivered children. For some of those women, however, the symptoms are severe enough to require medical intervention.
Starting in 1996, a number of medical device manufacturers began offering products intended to treat POP and SUI. These products were based on the surgical mesh that had been used to successfully treat abdominal hernias for decades, but unlike surgical mesh, these mesh products were implanted through a procedure that involved their insertion through the vaginal canal.
Within a few years of the introduction of transvaginal mesh products, the federal government’s Food and Drug Administration (FDA), which had never required that the products’ manufacturers provide any clinical evidence of their safety or efficacy, began receiving reports of trouble.
Thousands of women who had undergone transvaginal procedures to implant the mesh into their pelvic area were suffering symptoms that included the erosion of their vaginal tissue, chronic urinary tract infection (UTI), bleeding, hemorrhaging, organ perforation, and even death.
Today, the medical malpractice attorneys of Scartelli Olszewski, P.C. are helping women who have been victimized by the negligence of the device manufacturers who unleashed these largely untested products on a vulnerable patient population. If you’re suffering from health problems that you believe are connected to the use of transvaginal mesh to treat POP or SUI, we encourage you to contact us today